'Flawed': Experts dispute $100m talcum powder payout

EXPERTS are questioning a US court's decision to award $US72 million ($100 million) to the family of a woman whose death from ovarian cancer was linked to talcum powder.

Professor Paul Pharoah, professor of cancer genetic epidemiology at the University of Cambridge, describes the decision as “flawed” because of the weak evidence of a causal association between genital talc use and ovarian cancer risk.

Cancer Council Australia adviser Professor Bernard Stewart, from the University